Application of CB-839 in preparation of medicine for inhibiting corneal neovascularization

The invention belongs to the technical field of eye medicine preparation. The invention provides application of CB-839 in preparation of a medicine for inhibiting corneal neovascularization in order to solve the problem that complications can be caused by existing corneal neovascularization prevention and treatment means. The medicine loaded with the CB-839 can obviously inhibit mouse corneal neovascularization, inflammatory cell infiltration is reduced, no obvious side effect is found, and the defects in the prior art are overcome. 本发明属于眼部药品制备技术领域。针对目前角膜新生血管的预防与治疗手段会引发并发症的问题，本发明提供CB-839在制备抑制角膜新生血管生成的药物中的应用。本发明通过负载CB-839的药物能够明显抑制小鼠角膜新生血管生成，炎症细胞浸润减少，并且没有发现明显副作用，弥补了现有技术的不足。